Short answer
ImmunityBio, Inc. (IBRX) filed an 8-K current report with the SEC on June 10, 2026 reporting Item 5.07 (Submission of Matters to a Vote of Security Holders). Stockholders re-elected all nine directors for one-year terms ending at the 2027 annual meeting.
ImmunityBio, Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 5.07 · Submission of Matters to a Vote of Security Holders
- Stockholders re-elected all nine directors for one-year terms ending at the 2027 annual meeting
- 85% quorum, with 885,167,059 of 1,047,345,861 shares represented
- Director support remained strong, with 714,631,732–732,149,734 votes for each nominee
- Deloitte & Touche LLP ratified as independent auditor for fiscal year ending December 31, 2026
- Auditor appointment received 882,420,139 votes for versus 1,675,960 against
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other ImmunityBio, Inc. 8-K filings
Get the next IBRX 8-K as it lands
Follow IBRX for push alerts, or ask the research agent what this filing means.